Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$510.4M-4.1%$532.2M+8.3%$491.5M-8.0%$534.2M+3.7%$515.3M+13.2%
$153.2M-2.8%$157.6M+1.9%$154.7M-5.2%$163.2M+2.1%$159.8M-3.5%
-$285.8M-50.7%-$189.7M-2.0%-$186M+6.4%-$198.7M-74.0%-$114.2M+28.7%
$241.4M-18.3%$295.5M0.0%$295.5M-13.1%$340M+13.0%$300.8M+47.7%
$500K0.0%$500K+66.7%$300K-25.0%$400K+33.3%$300K-25.0%
-$232.8M+18.7%-$286.5M+8.4%-$312.7M+12.2%-$356.2M-12.5%-$316.5M-44.7%
-$14.1M-133%$42.4M+403%-$14M+61.1%-$36M
$357.2M-4.6%$374.6M+11.2%$336.8M-9.2%$371M+4.4%$355.5M+22.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Bio-Rad Laboratories, Inc. generate?
Bio-Rad Laboratories, Inc. (BIO.B) generated $510.4M in operating cash flow over the trailing twelve months.
What is Bio-Rad Laboratories, Inc.'s free cash flow?
After $153.2M of capital expenditures, Bio-Rad Laboratories, Inc.'s free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
Where does Bio-Rad Laboratories, Inc.'s cash flow data come from?
Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.